News

Cipla launches Cipremi for treatment for patients with severe COVID-19 disease

It is claimed to be the only US FDA approved Emergency Use Authorisation (EUA) treatment for adult and paediatric patients hospitalized with suspected or laboratory confirmed COVID-19 infection

Read More

Jun 23, 2020

By : Team ABLE

GSK’s China-based partner Clover begins phase I study on Coronavirus vaccine

The research collaboration with Clover Biopharmaceuticals to make COVID-19 S-Trimer vaccine (SCB-2019) vaccine candidate was announced by Glaxo in February.

Read More

Jun 23, 2020

By : Team ABLE

Praj, Lygos to co-develop advanced lactic acid yeast technology for bio-based products

Lygos will provide its proprietary yeast platform to Praj for jointly developing into various solutions for commercial applications.

Read More

Jun 23, 2020

By : Team ABLE

IIT Madras Researchers show ways to improve efficacy of anti-cancer treatments

The research team is now exploring collaborations with cancer hospitals to try their ‘simple timing’ strategy to enhance the effectiveness of cancer treatment

Read More

Jun 22, 2020

By : Team ABLE

Glenmark receives regulatory approval for oral antiviral drug Favipiravir; to market it under the brand name FabiFlu

FabiFlu is the first oral Favipiravir-approved medication in India for the treatment of COVID-19.

Read More

Jun 22, 2020

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights